【兵庫県神戸市】介護医療院

• 当直なし
• 週4以下
• オンコールなし

【神戸市内】科目不問！病棟管理メイン

勤務地

兵庫県神戸市

給与

1200万円 ～ 1500万円 応相談

募集科目

全科目不問

勤務内容

病棟、透析
・病棟管理
　療養病棟（1病棟36床）における患者様の全身管理・処方管理
　体制：常勤医2名体制（担当患者数：1人あたり18名程度）
　外来診療：なし（病棟管理メイン）
・院長（週4日勤務）の休日に伴い、週1回程度の外来透析患者および入院透析患者の回診・急変時対応業務あり
・日常的に行う管理・処置（必須）
　中心静脈栄養（CV）の管理・ポート管理
　経管栄養（胃ろう・腸ろう・経鼻栄養）の管理
　気管切開後の日常管理（カニューレ交換含む）
※スキル面で不安等あれば、随時担当者へご確認ください。

・スキル・ご経験に応じ相談可能な手技（非必須）
　胃ろう（PEG）交換（※院内対応が難しい場合は他医師への依頼や提携病院等での対応可）
　中心静脈カテーテル挿入（CV穿刺）
　急変時対応（基本的にはDNAR方針が固まっている患者様が多く、BLSレベルの初期対応お　よび必要に応じた転院搬送対応が中心）

【業務量目安】
病棟：30名（透析患者含む）
透析：10名前後
透析ベッド数：約30床


※外来診療、訪問診療は大歓迎です。

当直・オンコール：無

• 当直なし
• 週4以下

【神戸市】健診・人間ドック◎常勤医師募集！

勤務地

兵庫県神戸市内（2か所）

給与

1000万円 ～ 1500万円 応相談

募集科目

一般内科

勤務内容

健診、読影
健診診察、人間ドック診察、結果説明（労災二次・特定健診・ドック）、
予防接種問診、胸部レントゲン読影、その他健診・ドックに関連する業務

・診察件数　AM100名前後、PM50名前後　※閑散期繁忙期で差あり

• 当直なし
• 週4以下
• オンコールなし

【神戸市】健診医募集！

勤務地

兵庫県神戸市中央区

給与

996万円 応相談

募集科目

一般内科

勤務内容

健診
＜巡回健診＞
　巡回エリア：兵庫県内（豊岡、赤穂、尼崎、淡路島含む）
　企業規模：中小企業メイン
　健診内容：一般健診（問診、聴打診）特定健診（問診、聴打診）

　診察、問診
　・対応目安：繁忙期…多くて1日140～150名　閑散期…1日100名程
　巡回で1日1～3件を担当

　1日のスケジュール
　・クリニックに集合⇒巡回バスにて出発⇒各事業所で健診⇒クリニックへ戻る（※直行直帰不可です）

　※豊岡・篠山へ出張あり（二泊三日）…月2～3回を常勤医師で分担
　⇒1日目：移動・到着後、健診
　　2日目：終日　健診
　　3日目：終日　健診、終了後クリニックへ移動

【兵庫県】MD求人

勤務地

兵庫県内

給与

1400万円 応相談

募集科目

一般内科、小児科、その他（アレルギー科、免疫科）、製薬会社

勤務内容

その他
対象科目：内科、小児科、アレルギー科、免疫科

Basic purpose of the job
Senior CPhL-Asia supports the clinical development in Asia of new drugs and further development of approved drugs with emphasis on the design and execution of the Clinical Pharmacology (CP)development strategy.
CPhL-Asia is accountable and responsible for communicating with regulatory authorities on CP topics and for CP aspects of drug submission in Asia (e.g., submission summaries).
CPhL-Asia may act as trial clinical Pharmacologist (TCP; see TCP job profile) for clinical studies in their own project or outside of their own projects.
CPhL-Asia may serve as Clin Pharm representative within various teams in Asia (Japan/China) in support of early integration of Japan/China into global development program. Post PoCP, they may serve as CP and TMCP representative in various Asian teams until submission and launch. CPhL-Asia will also serve as main TMCP representatives in all PMO projects in Asia.

Accountabilities
Ensure timely delivery of state-of-the-art Clinical Pharmacology scientific concepts for decision making throughout clinical drug development and registration in Asia including all necessary processes and documentation.
Ensures timely delivery of state-of-the-art Clinical Pharmacology strategy development and implementation.
Senior CPhL-Asia is responsible for defining the CP strategy (for instance, defining the drug-drug interaction liability or formulation development strategy for modified release) of assigned project. CPhL-Asia is also responsible for refining the CP strategy in a timely manner as new data become available during drug development. As part of the strategy, CPhL-Asia may define CP aspects in a clin trial protocol and for an eventual submission and further phase IV activities.
Senior CPhL-Asia contributes to the Clin Pharm section of official documents (e.g., Information Brochure (IB), label); CPhL-Asia engages with regulatory agencies on matters pertaining to CP during drug development and are responsible for supporting Asian submission and post-submission activities with Clin Pharm and Biopharm expertise.
Clinical development project representative
Act as Clin Pharm representative in trial and project teams and regulatory meetings.
CPhL-Asia serves as Clin Pharm representative within various teams in support of early integration of Japan/China into global development program. Post PoCP, they may serve as CP and TMCP representative in various Asian teams until submission and launch. CPhL-Asia may also serve as main TMCP representatives in all PMO projects in Asia.
When delegating a trial to TCP, a CPhL-Asia is expected to ensure that adequate amount of information on the project and trial are provided to the TCP.
For instance, a CPhL-Asia is expected to discuss study design and project standards with the TCP.
A CPhL-Asia may function as a TCP in certain studies or projects.
Driving science and innovation
CPhL-Asia leads clinical development trial and project overarching topics from TMCP (e.g. by focus group).
CPhL-Asia represents Clinical Pharmacology or TMCP in internal and external initiatives/working groups.
CPhL-Asia continuously scouts, evaluates (incl piloting) and implements new methods and strategies in the area of Clinical Pharmacology.
Strategic partnerships:
CPhL-Asia implements collaborations and strategic partnerships with external bodies. They organize and manage projects with external organizations (e.g. CROs, ARO).
CPhL-Asia may serve as subject matter expert (CP, Biopharm) in in –or outlicensing activities

Functional processes:
CPhL-Asia continuously develops and refines further functional processes and infrastructure.
CPhL-Asia is CP (CP and Biopharm) experts and may offer this expertise to other interface functions (e.g, Toxicology, Pharmacovigilance, Customer Information, Marketing, Regulatory Affairs) or to support internal or external working groups.
CPhL-Asia presents results internally and externally as well as contributes to scientific publications.

Compliance (incl GCP):
CPhL-Asia follows all ICH GCP, other relevant authority regulations and internal guidance to protect the rights, safety and wellbeing of trial subjects, including sample chain of custody, data privacy and data integrity. In addition, obligations outside the field of clinical studies, such as EHS, Pharmacovigilance, anti-corruption, BI-internal guidance should be followed.